Cheever Charlie E III: insider trades.
Cheever Charlie E III reported 10 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 10 open-market purchases ($115K) and 0 sales, across 1 company.
- Transactions
- 10
- Purchases (P)
- 10
- Sales (S)
- 0
- Companies
- 1
- Name as filed
- CHEEVER CHARLIE E III
Companies
| Company | Relationship | Transactions |
|---|---|---|
| CV Sciences, Inc. (CVSI) | TenPercentOwner | 10 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-07 | CV Sciences, Inc. | P | 94,854 | $0.02 | 26,648,711 | Form 4 |
| 2026-08-04 | CV Sciences, Inc. | P | 108,000 | $0.02 | 26,553,857 | Form 4 |
| 2026-07-31 | CV Sciences, Inc. | P | 1,730,000 | $0.02 | 26,445,857 | Form 4 |
| 2026-07-29 | CV Sciences, Inc. | P | 60,000 | $0.02 | 24,715,857 | Form 4 |
| 2026-07-28 | CV Sciences, Inc. | P | 1,830,000 | $0.02 | 24,655,857 | Form 4 |
| 2026-07-24 | CV Sciences, Inc. | P | 470,075 | $0.02 | 22,825,857 | Form 4 |
| 2026-07-22 | CV Sciences, Inc. | P | 272,500 | $0.02 | 22,355,782 | Form 4 |
| 2026-07-21 | CV Sciences, Inc. | P | 335,000 | $0.02 | 22,083,282 | Form 4 |
| 2026-07-17 | CV Sciences, Inc. | P | 749,000 | $0.02 | 21,748,282 | Form 4 |
| 2026-07-16 | CV Sciences, Inc. | P | 91,387 | $0.02 | 20,999,282 | Form 4 |
Questions
What stock did Cheever Charlie E III buy or sell?
Cheever Charlie E III reported 10 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 10 open-market purchases ($115K) and 0 sales, across 1 company.
Is Cheever Charlie E III the same person as other filers with this name?
This page covers SEC CIK 1202557 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/cheever-charlie-e-iii-1202557.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.